Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Harding Loevner Emerging Markets Equity 2024 Q4 Investor Letter | Buyside Digest

Back to Fund Profile (Harding Loevner Emerging Markets Equity)

Primary Source Intelligence • Q4 2024 Letter Analysis

Harding Loevner Emerging Markets Equity Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Harding Loevner Emerging Markets Equity. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD-8.29%

YTD+2.38%

Annualized+8.9%

Positioning StanceConstructive

Market CapLarge Cap

GeographyEmerging markets, Asia, LatAM

Digest Analysis

Quick Take

"China's massive stimulus drove regional rebound while manager increased geographic diversification. Portfolio positioned in AI beneficiaries like TSMC and resilient global companies with diversified supply chains."

Executive Summary

Harding Loevner's Emerging Markets Equity strategy declined 8.1% in Q4 2024 as Trump's election victory sparked concerns about trade policy changes and higher interest rates. Despite the quarterly decline, the portfolio gained 2.4% for the full year. China rebounded 20% annually after launching its biggest stimulus package since the global financial crisis, including $1.4 trillion for local government support. The manager sold three Chinese holdings following the rally and increased diversification across India, Saudi Arabia, Taiwan, and Vietnam. Key return drivers include AI-enabled companies like TSMC, which expects 50% annual AI revenue growth, and resilient businesses with global supply chains like Midea and WEG. The portfolio benefits from secular themes including artificial intelligence adoption, energy transition, and healthcare expansion in Saudi Arabia. While trade policy uncertainty persists, the manager emphasizes that emerging markets are more economically resilient than eight years ago, with companies demonstrating strong competitive advantages and adaptation capabilities. The relative valuation case for emerging markets versus developed markets remains compelling.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

68%

CautiousHigh

Moderate (68%)

Manager demonstrates moderate-high conviction through specific position sizing decisions (selling three Chinese names, adding to specific geographies), detailed company analysis with named holdings and market share data, and clear thesis articulation around AI and supply chain resilience. Portfolio concentration and specific catalyst identification support conviction level.

Growth Outlook

25%

BearishBullish

Bearish (25%)

Manager expresses cautious optimism about emerging markets despite acknowledging trade policy uncertainties. Positive on China's stimulus measures and structural improvements in EM economies, but recognizes near-term headwinds from potential tariffs and policy changes.

Risk Appetite

15%

DefensiveAggressive

Defensive (15%)

Portfolio shows selective risk-taking through geographic diversification and new positions in healthcare, but manager sold Chinese holdings after rally and maintains neutral China weighting. Cash position at 2.4% indicates measured approach to deployment.

Capital Deployment

20%

De-riskingDeploying

De-risking (20%)

Manager engaged in active rotation by selling three Chinese holdings and adding to positions in India, Saudi Arabia, Taiwan, and Vietnam. Also established new healthcare positions. This represents selective redeployment rather than net cash deployment, indicating measured capital allocation.

Forward Guidance

10%

CautiousExpansionary

Cautious (10%)

Manager states intention to remain focused on fundamental research and companies with competitive advantages, but provides limited specific deployment guidance. Emphasis on patience and selectivity rather than aggressive positioning changes.

Language Signal

20%

BearishBullish

Bearish (20%)

Language balances opportunity identification (AI growth, stimulus benefits, attractive valuations) with risk acknowledgment (trade uncertainty, policy changes). More constructive than bearish but measured in tone throughout.

Perceived Risk

72%

Low RiskElevated

Elevated Risk (72%)

Manager identifies multiple significant risks including trade policy changes, China's economic downturn with social instability, Brazil's fiscal crisis, and Mexico's political uncertainty. Detailed discussion of tariff impacts and geopolitical tensions indicates high awareness of macro risks.

Opportunity Density

65%

ScarceAbundant

Abundant (65%)

Manager identifies selective opportunities in AI beneficiaries, healthcare expansion in Saudi Arabia, and companies with diversified supply chains. Emphasizes that EM landscape is 'different and in many ways better' than eight years ago, suggesting moderate opportunity set requiring selectivity.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

Manager focuses on long-term competitive advantages and companies that can 'adapt and outcompete through changing industry structures.' Discussion of multi-year themes like AI revenue growth over five years and structural economic improvements indicates patient, multi-year investment horizon.